Profil
Hitoshi Miyakoshi joined Taiho ventures in 2021.
He worked at Taiho Pharmaceutical for 16 years as a medicinal chemist in drug discovery for anti-cancer agents.
He led cancer metabolism and brain cancer projects as a chemistry leader, including dUTPase/DPD dual inhibitor (TAS-114) and brain-penetrable drug discovery projects.
Besides that, he also engaged in open-innovation support in a wide range of drug discovery field at Taiho.
He received his PhD in pharmaceutical and medicinal chemistry from Gifu Pharmaceutical University.
Postes actifs de Hitoshi Miyakoshi
| Sociétés | Poste | Début |
|---|---|---|
Taiho Ventures LLC
 Taiho Ventures LLC Investment ManagersFinance Taiho Ventures LLC (Taiho Ventures) is a venture and private equity subsidiary of Taiho Pharmaceutical Co Ltd founded in 2016. The firm is headquartered in Menlo Park, California. | Private Equity Investor | 01/01/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Taiho Ventures LLC
Taiho Ventures LLC Investment ManagersFinance Taiho Ventures LLC (Taiho Ventures) is a venture and private equity subsidiary of Taiho Pharmaceutical Co Ltd founded in 2016. The firm is headquartered in Menlo Park, California. | Finance |
